Table 2.
Drug class | Drug | Mechanism | The influence on cholesterol | The influence on PXR | Reference |
---|---|---|---|---|---|
Antibiotic | Rifampicin | Bacterial RNA synthesis inhibition | CHOL&LDL↑ | PXR agonist | (135, 136) |
Anticonvulsant | Carbamazepine | Blocking of central Na+ channel | CHOL&LDL↑ | PXR agonist | (18, 137) |
Antihypertensive | Lacidipine | Ca2+ channel blocker | LDL↑ | PXR agonist | (138) |
Antineoplastic | Apalutamide | Antiandrogen | CHOL&LDL↑ | Possible PXR agonist | (139) |
Mitotane | Adrenal cortex inhibition | CHOL&LDL↑ | PXR agonist | (140–142) | |
Ruxolitinib | JAK inhibition | CHOL↑ | Possible PXR agonist | (98) | |
Brigatinib | Tyrosine kinase inhibition | CHOL&LDL↑ | Possible PXR agonist | (98) | |
Dasatinib | Tyrosine kinase inhibition | CHOL&LDL↑ | PXR agonist | (138) | |
Nilotinib | Tyrosine kinase inhibition | CHOL&LDL↑ | PXR agonist | (143) | |
Antipsychotic, atypical | Quetiapine | Inhibition of D2 and 5-HT2A receptors | CHOL&LDL↑ | PXR agonist | (95) |
Antiretroviral | Efavirenz | Non-nucleoside reverse transcriptase inhibition | CHOL&LDL↑ | PXR agonist | (21, 144, 145) |
Etravirine | Non-nucleoside reverse transcriptase inhibition | CHOL&LDL↑ | PXR agonist | (146–149) | |
Rilpivirine | Non-nucleoside reverse transcriptase inhibition | CHOL&LDL↑ | PXR agonist | (146) | |
Darunavir | Protease inhibition | CHOL↑ | PXR agonist | (21) | |
Fosamprenavir | Protease inhibition | CHOL↑ | PXR agonist | (150) | |
Lopinavir | Protease inhibition | CHOL↑ | PXR agonist | (21) | |
Ritonavir | Protease inhibition | CHOL↑ | PXR agonist | (151) | |
Saquinavir | Protease inhibition | CHOL&LDL↑ | PXR agonist | (151) | |
Barbiturate | Phenobarbital | GABA stimulation | LDL↑ | PXR agonist | (152, 153) |
Immunosuppressant | Cyclosporin | Calcineurin inhibition | CHOL&LDL↑ | PXR agonist | (154) |
Tacrolimus | Calcineurin inhibition | CHOL↑ | PXR agonist | (155) | |
Dexamethasone | Glucocorticoid receptor activation | CHOL↑ | PXR agonist | (10, 156, 157) | |
Proton pump inhibitor | Lansoprazole | Stomach acid reduction | CHOL↑ | PXR agonist | (158) |
Stimulant | Modafinil | Dopaminergic modulation | CHOL↑ | PXR agonist | (159) |